Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Horizon Pharma

Horizon Pharma reported $76.62M in Trade Creditors for its fiscal quarter ending in March of 2023.

Trade Creditors Change
Bausch Health Companies Inc VRX:CN USD 561M 40M
Cara Therapeutics CARA:US USD 4.42M 5.18M
Coherus Biosciences CHRS:US USD 23.23M 11.7M
Eli Lilly LLY:US USD 2.02B 85.3M
Endo International ENDP:US USD 96.75M 12.28M
Horizon Pharma HZNP:US USD 76.62M 79.18M
Novartis NOVN:VX USD 5.43B 280M
Pacira PCRX:US USD 17.26M 2.04M
Perrigo PRGO:US USD 505.2M 32.1M
Prestige Brands PBH:US USD 62.74M 1.51M
Revance Therapeutics RVNC:US USD 13M 8.45M
Supernus Pharmaceuticals SUPN:US USD 11.54M 1M
Takeda 4502:JP JPY 649.23B 268.12B
Xeris Pharmaceuticals Inc XERS:US USD 11.98M 7.38M
Zoetis ZTS:US USD 424M 19M